Gorodeski, George I. Calcium regulates estrogen increase in permeability of cultured CaSki epithelium by eNOS-dependent mechanism. Am J Physiol Cell Physiol 279: C1495-C1505, 2000.-Estrogen increases baseline transepithelial permeability across CaSki cultures and augments the increase in permeability in response to hypertonic gradients. In estrogen-treated cells, lowering cytosolic calcium abrogated the hypertonicity-induced augmented increase in permeability and decreased baseline permeability to a greater degree than in estrogen-deprived cells. Steady-state levels of cytosolic calcium in estrogen-deprived cells were higher than in estrogen-treated cells. Increases in extracellular calcium increased cytosolic calcium more in estrogen-deprived cells than in estrogen-treated cells. However, in estrogen-treated cells, increasing cytosolic calcium was associated with greater increases in permeability in response to hypertonic gradients than in estrogen-deprived cells. Lowering cytosolic calcium blocked the estrogen-induced increase in nitric oxide (NO) release and in the in vitro conversion of L-
H]arginine to L-[
3 H]citrulline. Treatment with estrogen upregulated mRNA of the NO synthase isoform endothelial nitric oxide synthase (eNOS). These results indicate that cytosolic calcium mediates the responses to estrogen and suggest that the estrogen increase in permeability and the augmented increase in permeability in response to hypertonicity involve an increase in NO synthesis by upregulation of the calciumdependent eNOS. paracellular permeability; transepithelial transport; cervical mucus; cytosolic calcium; nitric oxide; nitric oxide synthase; G-actin; cytoskeleton; endothelial nitric oxide synthase THE MAIN FUNCTION OF THE UTERINE cervical epithelium is to control secretion of cervical mucus. The cervical mucus is important for reproduction and for woman's health. Abnormal secretion of cervical mucus may lead to infertility and to states of disease such as mucorrhea and dryness dyspareunia (14) .
The cervical mucus is a mixture of mucins and cervical plasma. Mucins are secreted in the cervical canal by exocytosis from endocervical cells (14) . The cervical plasma composes 80-99% of the total weight of the cervical mucus, and it originates by transudation of fluid from the blood (14) . The driving force is the blood pressure: it generates a hydrostatic gradient between the capillaries and the cervical canal and compels movement of fluid through the intercellular (paracellular) space into the lumen (48) . Cervical epithelial cells control the free movement of fluid through the cervix by forming two functional barriers: the tight junctional resistance (R TJ ) and the resistance of the lateral intercellular space (R LIS ; see Ref. 15 ). According to the equivalent electrical circuit model of ion transport the sum of R TJ and R LIS in series determines the overall permeability of the cervical epithelium (41, 47) .
In human cervical epithelial cells, the R TJ and R LIS can be independently regulated (15) , but the mechanisms of regulation are not entirely understood. An example is the effect of estrogen on cervical permeability. Estrogen increases cervical secretions in women (14) . Studies at the cellular level revealed that the effect of estrogen involves an increase in R LIS (16) and is mediated by estrogen receptor ␣-activation of the nitric oxide (NO)/cGMP-dependent increase in G-actin (18, 24) . The proposed molecular mechanism of increase in permeability is modulation of the cytoskeleton. By shifting actin steady state toward G-actin, estrogen stimulates transformation of the cytoskeleton in a more flexible structure (16) . This renders cervical epithelial cells more deformable in response to the prevailing blood pressure-induced hydrostatic pressure and results in a greater decrease in R LIS and an increase in the permeability (16, 17) .
Calcium regulates paracellular permeability of cultured human cervical epithelia (23) . Calcium increases the R TJ by maintaining the tight junctional elements in a closed state (27) . Also, fluctuations in cytosolic calcium can modulate agonist-induced changes in R TJ and the R LIS (23, 25, 27) . Until recently, little was known about the role of calcium in the responses to estrogen. Calcium levels in cervical secretions change during the cycle (14) , suggesting that estrogen modulates transcervical transport of calcium. Changes in extracellular calcium can regulate paracellular permeability directly by changing the gating status of the tight junctions (27) or indirectly by modulating levels of cytosolic calcium (23) . Consequently, if estrogen signaling depends on calcium signaling, changes in extracel-lular calcium can affect the estrogen increase in cervical secretions by modulation of intracellular calcium activity. The objective of the present study was to determine the degree to which changes in cytosolic calcium modulate the effect of estrogen on cervical permeability.
METHODS

Cell cultures.
The experiments utilized CaSki cells, which are a stable line of transformed cervical epithelial cells that express phenotypic markers of the endocervix (26) . Cells were grown and maintained in a culture dish at 37°C in a 91% O 2 -9% CO 2 humidified incubator and were routinely tested for mycoplasma. For experiments, cells were plated on filters for 8 h and then shifted to steroid-free medium (16) . After 3 days, cells were treated with 10 nM 17␤-estradiol (estrogen-treated cells) or the vehicle (estrogen-deprived cells) for two additional days. Before assays, filters containing cells were washed three times and preincubated for 15 min at 37°C in a modified Ringer buffer (16, 24) .
Changes in paracellular permeability. Changes in paracellular permeability were determined in terms of changes in transepithelial electrical conductance (G TE ). Changes in G TE were determined continuously across filters mounted vertically in a modified Ussing chamber from successive measurements of transepithelial electrical current (⌬I) and of the transepithelial potential difference (⌬PD, lumen negative): G TE ϭ ⌬I/⌬PD. Transepithelial hypertonic gradients in the subluminal to luminal direction were established by adding aliquots of 2 M sucrose solution to the subluminal solution (15, 20) .
Determinations of cytosolic calcium. Determinations of cytosolic calcium in cells attached on filters were published previously (28) . Briefly, cells on filters were loaded with 7 M fura 2, and measurements of fluorescence were conducted in a custom-designed fluorescence chamber as described (4, 28) . Cells were illuminated over the apical surface, and the intensity of the emitted light from the apical surface was measured. Changes in cytosolic calcium were determined by switching the excitation filters to record the maximal (340-nm excitation/510-nm emission) and minimal (380-nm excitation/510-nm emission) fluorescence for cytosolic calcium determinations (4, 28) and were calculated according to the formula [Ca 2ϩ (30) , where [Ca 2ϩ ] i is the level of cytosolic calcium, R is the ratio of fluorescence excitation measurements at 340 to 380 nm, R min and R max are the experimentally determined minimum and maximum calcium measurement ratios at 340 and 380 nm, respectively, K d is the dissociation constant for fura 2 (224 nM), and S f2 /S b2 is the ratio of fluorescence value at 380-nm excitation determined at R min (0 calcium) and R max (maximal calcium). Maximal calcium fluorescence was obtained by adding 10 M ionomycin in the presence of 10 mM CaCl 2 , and minimal calcium fluorescence was obtained by competing calcium from fura 2 with 2.5 mM MnCl 2 .
Determinations of free calcium. Levels of calcium in the extracellular buffer were manipulated using the calcium chelator EGTA. Concentrations of free calcium in the extracellular buffer were calculated as described (23, 25) .
DNase I inhibition assay. DNase I inhibition assay was described (16) . G-actin content in lysates of cells grown on filters was determined in terms of DNase I inhibition of DNA degradation, based on the fact that under the conditions of the experiment the main inhibitor of DNase I is G-actin (2). Total actin was measured by incubating lysates with guanidine hydrochloride to depolymerize F-actin to monomeric G-actin. Data of the G-actin and total cellular actin were expressed per milligram total protein.
Release of NO. Release of NO was determined as the accumulation of nitrite and nitrate in the extracellular medium by a modified Greiss method as described (4). The detection limit of the assay was 2 M, and results were expressed as picomoles per minute per milligram of protein.
Nitric oxide synthase activity. Nitric oxide synthase (NOS) activity was assayed by following the conversion of L- [2, 3, 4, H]arginine to L- [2,3,4,5- 3 H]citrulline as described (43) with modifications. Before experiments, cells on filters were washed three times with PBS (37°C) and lysed on ice for 20 s with buffer (1 l/10 4 cells at 20°C, pH 7.4) containing 320 mM sucrose, 0.1 mM EDTA, 1 mM dithiothreitol, 10 mM HEPES, 10 g/ml soybean trypsin inhibitor, 10 g/ml leupeptin, and 2 g/ml aprotinin. Aliquots were removed for DNA. The lysates were centrifuged (10 4 g for 20 min at 4°C), and the supernatants were assayed in triplicate. The supernatant (100 l, about 200 g of cell protein) was incubated with 100 l of buffer (40 mM 
. Samples were incubated for 30 min at 37°C before the reaction was terminated by adding 500 l of H 2 O-Dowex-50W (1:1 vol/vol; Na ϩ form). The resin-incubated mixture was dispersed and diluted by adding 860 l of 2dH 2 O. The resin was allowed to settle for 15 min, and 975 l of supernatant were pipetted into scintillation vials. Scintillation counting fluid (10 ml) was added to each vial, and the radioactivity corresponding to L- [2,3,4,5- 3 H]citrulline was measured. NOS activity was expressed as picomoles per minute per milligram of DNA. The calcium-dependent NOS activity was determined from the difference between activities obtained in control and in EGTA (or L-NAME, L-NA, or L-NMMA) buffers; total activity of the NOS was determined by subtracting the activities obtained in EGTA plus L-NAME buffers.
Molecular biology methods. Molecular biology methods were described (19) . Total RNA from cultured cells was isolated with the Qiagen kit (Qiagen, Chatsworth, CA; see Ref. 19) . The method for RT-PCR was described (19) . The following PCR conditions were applied: for endothelial nitric oxide synthase (eNOS), 35 cycles of 1-min denaturation step at 94°C, 1 min of annealing step at 62°C, and 2 min of extension step at 72°C; for neuronal (brain) nitric oxide synthase (bNOS), 35 cycles of 1 min at 94°C, 2 min at 56°C, and 2 min at 72°C; for the inducible nitric oxide synthase (iNOS), 35 cycles of 1 min at 94°C, 2 min at 56°C, and 2 min at 72°C. The following oligonucleotide primers were used: human eNOS (34) 5Ј-forward (sense) 5Ј-CAG TGT CCA ACA TGC TGC TGG AAA TTG-3Ј, 3Ј-reverse (antisense) 5Ј-TAA AGG TCT TCT TGG TGA TGC C-3Ј; human bNOS (38) 5Ј-forward (sense) 5Ј-TTT CCG AAG CTT CTG GCA ACA GCG GCA ATT-3Ј, 3Ј-reverse (antisense) 5Ј-GGA CTC AGA TCT AAG GCG GTT GGT CAC TTC-3Ј; iNOS (11) 5Ј-forward (sense) 5Ј-GCC TCG CTC TGG AAA GA-3Ј, 3Ј-reverse (antisense) 5Ј-TCC ATG CAG ACA ACC TT-3Ј. X-ray films were analyzed with a laser densitometer Sciscan 5000 (United States Biochemical, Cleveland, OH) and normalized relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA (19) .
Total protein and total DNA. Total protein and total DNA were measured as described (21, 22) .
Cell viability. Cell viability was determined by mitochondrial respiration assay using dimethylthiazol diphenyl tetrazolium (MTT) staining (46) . Cells on filters were incubated for 60 min at 37°C in Ringer buffer containing 1 mg/ml MTT. Cultures were washed with PBS and solubilized in isopropanol containing 0.1 M HCl and 1% Triton X-100. Lysates were mixed by pipetting to dissolve the reduced MTT crystals and were spun at 10,000 g for 5 min. The solubilized formazan was measured by determining absorption at 575 nm minus background absorbance at 690 nm for each sample. In control experiments, cells were treated for 30 min with 50 M of the protonophore uncoupler carbonyl cyanide m-chlorophenylhydrazone (mClCCP; Aldrich, Milwaukee, WI). Viability was defined as Ͻ5% positive staining compared with control (mClCCP-treated) cells.
Drugs treatments. For experiments with cells on filters, all reagents, except sucrose, were added from concentrated (1,000-300ϫ) stocks (pH 7.2) of saline, PBS, ethanol, or DMSO to both the luminal and subluminal solutions. Aliquots of sucrose solution were added only to the subluminal solution.
Statistical analysis of the data. Data are presented as means Ϯ SD, and significance of differences among means was estimated by ANOVA. Trends were calculated using GB-STAT V5.3 (Dynamic Microsystems, Silver Spring, MD) and were analyzed with ANOVA. Best fit of regression equations (least squares criterion) was achieved with SlideWrite Plus (Advanced Graphics Software, Carlsbad, CA), which uses the Levenberg-Marquardt Algorithm, and was analyzed using ANOVA.
Chemicals and supplies. L-[2,3,4,5-3 H]arginine monohydrochloride was obtained from American Radiolabled Chemicals (St. Louis, MO). Anocell (Anocell-10) filters were obtained from Anotec (Oxon, UK). Fluorescent microspheres (FluoresBrite beads, calibration grade) were obtained from Polysciences (Warrington, PA). All other chemicals were obtained from Sigma Chemicals.
RESULTS
Experimental design to test effects of cytosolic calcium on paracellular permeability.
The main objective of the study was to determine the degree to which changes in cytosolic calcium affect the estrogen-induced increases in paracellular permeability. To manipulate cytosolic calcium, CaSki cells attached on filters were exposed to the following conditions.
To increase cytosolic calcium, extracellular calcium was increased above the physiological level of 1.2 mM to augment calcium influx. In cells grown in regular medium, raising extracellular calcium from 1.2 to 4.0 mM increased cytosolic calcium from 89 to 97 nM (P Ͻ 0.01, paired t-test), but it had no effect on G TE (Fig. 1A) .
To decrease cytosolic calcium, cells were treated with EGTA to lower extracellular calcium and to decrease calcium influx (23) . In cells grown in regular medium, lowering extracellular calcium from 1.2 to 0.6 mM decreased cytosolic calcium acutely from 91 Ϯ 5 to 66 Ϯ 5 nM (P Ͻ 0.01, paired t-test; Fig. 2 ). Lowering extracellular calcium also increased G TE acutely (Fig. 2) . The effect of low extracellular calcium on G TE could be the result of an effect on the tight junctions at extracellular sites [by changing the gating properties of the tight junctional elements (25, 27) ] or secondary to lowered cytosolic calcium (13, 31) . To discern between these two mechanisms, it was necessary to abrogate the low-calcium-related increase in G TE that was induced by direct modulation of the tight junctions. This was done by adding MnCl 2 at equimolar concentrations to the calcium that was chelated by EGTA (27) . As is shown in Fig. 2 , MnCl 2 reversed the increase in G TE ; the mechanism of Mn 2ϩ action on G TE is unknown, but it is not the result of changes in cytosolic calcium, since (G TE ) .Shown is an experiment done on CaSki cells plated on filters and maintained in regular culture medium. Determinations of Ca i levels were done in the fluorescence chamber (E, see METH-ODS), and determinations of changes in G TE were done in the Ussing chamber (F). Where indicated by arrows, extracellular calcium was increased to the designated level by adding aliquots from concentrated CaCl 2 solution incrementally. The experiment was repeated two times (total of 5 filters) with similar effects. In all cases, Ca i increased significantly (P Ͻ 0.01 paired t-test); means of Ca i were 89 Ϯ 6 nM at Ca o of 1.2 mM and 97 Ϯ 5 nM at Ca o of 4.0 mM. B: effects of increasing osmolarity in the subluminal solution on G TE . Shown is an experiment done on CaSki cells plated on filters and maintained in regular culture medium. Where indicated by arrows, osmolarity in the subluminal solution was increased to the designated level by adding aliquots from concentrated sucrose solution to the subluminal solution incrementally. The experiment was repeated three times (total of 8 filters) with similar effects. In all cases, G TE increased significantly (P Ͻ 0.01 paired t-test); means of G TE were 71 Ϯ 8 mS/cm 2 at isotonic conditions and 105 Ϯ 9 mS/cm 2 at 330 mosmol/l.
Mn
2ϩ had no effect on intracellular fura 2 fluorescence (Fig. 2) .
To determine conditions in which lowering cytosolic calcium does affect permeability, cells were depleted of cytosolic calcium by using repeated administrations of the calcium ionophore ionomycin. In CaSki cells, ionomycin increases cytosolic calcium and G TE transiently and acutely (23) . The effect is the result of calcium mobilization from intracellular stores (including mitochondria), and cells replenish intracellular calcium by augmented capacitative calcium influx (23, 28) . The duration of the increases in cytosolic calcium and in G TE depends on extracellular calcium: at Ն1.2 mM calcium, the increases last Ͼ10 min (23, 28) , even if cells are treated with increasing concentrations of ionomycin (Table 1 ). In cells bathed in low calcium (0.6 mM), the effects are shorter and last only 3-5 min (Fig.  2) , probably due to incomplete replenishment of calcium stores (23, 25) . Repeat applications of ionomycin to cells bathed in low calcium resulted in smaller increases in cytosolic calcium and in G TE ; after a third treatment with ionomycin, there were no additional increases in cytosolic calcium or in G TE ( Fig. 2 and Table 1 ), suggesting that intracellular stores became depleted of calcium. Under these conditions, G TE decreased slowly but persistently ( Fig. 2; see also Fig. 3 ).
The effects of EGTA, Mn 2ϩ , ionomycin, and CaCl 2 were reversible upon restoring extracellular calcium to 1.2 mM; levels of G TE returned to baseline, and cells regained their responsiveness to ionomycin (data not Fig. 3 . Effects of estrogen, low extracellular calcium, and hypertonicity on G TE levels. Changes in G TE (means Ϯ SD) were determined in estrogen-deficient (ϪE) or in estrogen-treated CaSki cells (ϩE) at the following three time points: 1) at baseline, before lowering extracellular calcium (Pretest); 2) 20 min after treatment with 0.6 mM EGTA, 0.6 mM Mn 2ϩ , and 5 M ionomycin (Low Ca, see Fig. 1 for details); these measurements were done in isotonic buffer (285 mosmol/l); 3) 3 min after increasing the osmolarity of the subluminal solution from 285 mosmol/l to either 300, 315, or 330 mosmol/l. Experiments were repeated three times with 3-6 filters in each experiment. Ca 1.2 mM, experiments done on cells bathed in normal extracellular calcium (1.2 mM). The findings are described in RE-SULTS. *P Ͻ 0.05-0.01 (ANOVA) for ϩE/Ca 1.2 vs. ϩE/Low Ca and for ϪE/Ca 1.2 vs. ϪE/Low Ca. **P Ͻ 0.01 (ANOVA) for ϩE/Ca 1.2 vs. ϪE/Ca 1.2. ***P Ͻ 0.05 (paired t-test) for Ca 1.2 vs. Low Ca in both ϩE and ϪE groups. shown). Staining with MTT was negative, indicating that none of the agents produced toxic effects on the cells. In subsequent experiments, we used treatments with EGTA-Mn 2ϩ -ionomycin as the method to lower cytosolic calcium and deplete intracellular calcium stores.
Increases in extracellular calcium to 4.0 mM had no effect on the responses to ionomycin (Table 1) .
Estrogen increases baseline permeability and augments effects of hypertonicity and ionomycin. To determine the degree to which changes in cytosolic calcium affect the estrogen-induced increase in paracellular permeability, CaSki cells on filters were treated with 17␤-estradiol at the physiological concentration of 10 nM. The following two control conditions were used: 1) cells grown in estrogen-deficient medium and considered to be estrogen depleted and 2) cells exposed to a hypertonic gradient in the subluminal to luminal direction. Both treatments with estrogen and hypertonic gradients in the subluminal to luminal direction increase permeability across cultured human cervical epithelia by decreasing the resistance of the lateral intercellular space R LIS (16, 20) . However, the effects have different time courses and involve different cellular/molecular mechanisms: treatment with estrogen requires hours (16) , whereas hypertonic gradients increase G TE instantaneously (Fig. 1B and Refs. 15 and 20) . Also, estrogen increases G TE by fragmenting the cytoskeleton (16), whereas hypertonic gradients in the subluminal to luminal direction dilate the lateral intercellular space by stimulating water efflux (15, 20) .
Baseline levels of G TE across cultures of estrogendeprived CaSki cells ranged 51 Ϯ 5 mS/cm 2 (ϳ20 ⍀ ⅐ cm 2 ; Fig. 3 ). Treatment with 17␤-estradiol increased G TE to 95 Ϯ 5 mS/cm 2 ( Fig. 3 , P Ͻ 0.01), confirming our previous studies (16, 24) . In estrogen-deficient cells, hypertonic gradients in the subluminal to luminal direction increased G TE acutely (Fig. 2) and in a concentration-related manner (Fig. 3) , confirming our previous studies (15, 40) . A similar effect was also observed in estrogen-treated cells, but the responses were significantly greater in the latter (Fig. 3) . For instance, in estrogen-treated cells, a hypertonic gradient of 45 mosmol/l increased G TE by 83 mS/cm 2 compared with 27 mS/cm 2 in estrogen-deficient cells ( Fig. 3 , P Ͻ 0.01). These results indicate that treatment with estrogen increases baseline permeability and that it augments the increase in permeability in response to hypertonic gradients.
Treatment with 17␤-estradiol had no significant effect on the ionomycin-induced increase in cytosolic calcium, but it augmented the increase in G TE in response to ionomycin (Table 1) . In contrast to hypertonic gradients, changes in G TE in response to ionomycin were critically dependent on extracellular calcium ( Fig.  2 and Table 1 ). We therefore used hypertonic gradients as the second independent method (in addition to estrogen) to determine effects of cytosolic calcium on G TE .
Calcium depletion decreases G TE . The ionomycininduced depletion of cytosolic calcium decreased G TE . The effect was small in estrogen-deficient cells (Fig. 3) , but in estrogen-treated cells G TE decreased significantly by ϳ20 mS/cm 2 30-40 min after adding EGTAMn 2ϩ -ionomycin (Fig. 3 , 285 mosmol/l). These results indicate that depletion of intracellular calcium decreases permeability to a greater degree in estrogentreated cells than in estrogen-deficient cells.
Restitution of extracellular calcium to 1.2 mM resulted in a slow but complete reversal of baseline cytosolic calcium and G TE to levels that were observed before the treatments with EGTA-Mn 2ϩ -ionomycin (data not shown). Increasing extracellular calcium above 1.2 mM had no effect on baseline G TE (data not shown).
Lowering cytosolic calcium alters the responses to hypertonicity. In estrogen-deficient cells, treatment with EGTA-Mn 2ϩ -ionomycin slightly attenuated the responses to hypertonic gradients (Fig. 3) . In estrogentreated cells, treatment with EGTA-Mn 2ϩ -ionomycin abrogated the responses to hypertonic gradients; for instance, in estrogen-treated, calcium-depleted cells, a hypertonic gradient of 45 mosmol/l increased G TE only by 25 mS/cm 2 compared with 85 mS/cm 2 in cells bathed in normal calcium ( Fig. 3 , P Ͻ 0.01). This result indicates that in estrogen-treated cells most of the increase in permeability in response to hypertonic gradient depends on calcium.
Increasing extracellular calcium above 1.2 mM had no significant effect on the responses to hypertonic gradients, neither in estrogen-deficient nor in estrogen-treated cells (data not shown).
Estrogen modulates cytosolic calcium. To better understand the effect of cytosolic calcium on the responses to hypertonicity, levels of cytosolic calcium were determined in the range of extracellular calcium of 0.6-4.0 mM, and levels of cytosolic calcium were correlated with levels of G TE in response to a hypertonic gradient of 45 mosmol/l in the subluminal to luminal direction. In estrogen-deprived cells, steadystate levels of cytosolic calcium were higher than in estrogen-treated cells (Figs. 4 and 5A) . Changing extracellular calcium in the range of 0.6-4.0 mM increased cytosolic calcium both in estrogen-deprived cells and in estrogen-treated cells (Figs. 4 and 5A ), but cytosolic calcium increased more in estrogen-deprived cells than in estrogen-treated cells (Fig. 5A) .
Changing extracellular calcium also produced concentration-related changes in the hypertonicity-induced increase in permeability (Fig. 4) . To determine the degree to which these changes are related to cytosolic calcium, the data in Fig. 4 were analyzed in terms of the net increase in G TE (⌬G TE ) relative to changes in cytosolic calcium. In estrogen-treated cells, increases in cytosolic calcium had a greater effect on ⌬G TE than in estrogen-deprived cells (Fig. 5B) . By extrapolation, in estrogen-treated cells cytosolic calcium increased ⌬G TE at a rate of 3.0 mS ⅐ cm Ϫ2 ⅐ nM cytosolic calcium
Ϫ1
in contrast to 0.3 mS ⅐ cm Ϫ2 ⅐ nM cytosolic calcium Ϫ1 in estrogen-deficient cells (Fig. 5B , P Ͻ 0.01). These results indicate that treatment with estrogen sensitizes cells to cytosolic calcium and promotes larger increase in permeability in response to hypertonicity. Figs. 4 and 5 is that calcium regulates critical steps along the signaling cascade that mediates the estrogen increase in permeability. Estrogen increases transcervical paracellular permeability by a mechanism that involves estrogen receptor ␣-activation of the NO/cGMP-depen- Fig. 4 . Effects of changes in extracellular calcium on levels of cytosolic calcium and on changes in G TE in response to subluminal to luminal hypertonic gradient of 45 mosmol/l (⌬G TE ). Experiments were done in the Ussing chamber (for measurements of changes in G TE ) and in the fluorescent chamber (for measurements of changes in cytosolic calcium) using a design similar to that in Figs. 2 and 3 . Levels of extracellular calcium were lowered from 1.2 mM to 0.9 or 0.6 mM by adding 0.3 or 0.6 mM EGTA, respectively, followed by 0.3 or 0.6 mM MnCl 2 to restore G TE to baseline levels and 5 M ionomycin three times to deplete cytosolic calcium. Extracellular calcium was increased to 2.5 and 4.0 mM by adding aliquots from 1 M CaCl 2 solution. After treatment (20 min) with EGTA-Mn 2ϩ -ionomycin or with CaCl 2 , aliquots of 2 M sucrose solution were added to the subluminal compartment to establish a hypertonic gradient of 45 mosmol/l in the subluminal to luminal direction. Determinations of cytosolic calcium and changes in G TE were done 3 min after establishing the hypertonic gradient. ⌬G TE levels were calculated by subtracting G TE levels that prevailed 10 min after the third addition of ionomycin (see Fig. 2 ) from G TE levels recorded 3 min after establishing the hypertonic gradient. Shown are mean levels of cytosolic calcium (x-axis) and ⌬G TE (z-axis); experiments were repeated three times, with 3-5 filters in each experiment. Variability ranged 7-11% (also see Fig. 5 ). dent increase in G-actin (18, 24) . The objectives of the following two experiments were to test the degree to which the effects of NO and cGMP on G TE are dependent on calcium.
Cytosolic calcium does not modulate the effects of sodium nitroprusside and bromo-cGMP on G TE . A possible explanation for the results shown in
The first experiment tested effects of calcium on the responses to sodium nitroprusside (SNP) and 8-bromo (Br)-cGMP. SNP, an NO donor, and 8-Br-cGMP, a stable cell-permeable analog of cGMP, can also increase G TE by upregulation of G-actin (17, 24) . In estrogen-deprived cells bathed in normal calcium, SNP or 8-Br-cGMP increased G TE by ϳ50 mS/cm 2 above baseline (Fig. 6A, compare with Fig. 3) . A similar effect was observed in cells treated with EGTA-Mn 2ϩ -ionomycin (Fig. 6A) , indicating that lowering cytosolic calcium does not modulate effects of SNP or of 8-Br-cGMP on permeability. In SNP-or in 8-Br-cGMP-treated cells, hypertonicity increased G TE further by ϳ75 mS/ cm 2 , regardless whether the cells were previously treated with EGTA-Mn 2ϩ -ionomycin (Fig. 6A) . This is in contrast to the effect in estrogen-treated cells where treatment with EGTA-Mn 2ϩ -ionomycin attenuated the increase in G TE in response to hypertonicity (Figs. 3  and 6A ).
The second experiment tested the effects of calcium on the SNP-, 8-Br-cGMP-, and estrogen-induced increase in G-actin (Fig. 6B ). The experimental design was similar to that in Fig. 6A , except that the end point was G-actin. In estrogen-deprived cells, SNP and BrcGMP increased G-actin sixfold compared with control cells, regardless if cells were bathed in normal calcium (Fig. 6B) or if they were treated with EGTA-Mn 2ϩ -ionomycin (Fig. 6B) . This result differed from that in cells treated with estrogen: in estrogen-treated cells that were incubated in normal calcium, G-actin was 2.5-fold higher than in estrogen-deficient cells; when calcium was lowered with EGTA-Mn 2ϩ -ionomycin, Gactin was only 1.2-fold higher (Fig. 6B, P Ͻ 0.02) . Collectively, the results shown in Fig. 5, A and B , indicate that lowering calcium attenuates the hypertonicity-dependent increase in G TE and the increase in G-actin induced by estrogen, but not by SNP or by 8-Br-cGMP.
Calcium modulates the estrogen increase in NO synthesis. A possible explanation for the lack of effect of lowering calcium on the SNP-or 8-Br-cGMP-induced increase in G-actin and in the hypertonicity-induced increase in G TE is that calcium regulates signaling steps more proximal to the action of NO. The three experiments in this section tested the hypothesis that the calcium-sensitive step is estrogen upregulation of NO.
NO is synthesized from L-arginine during the NOScatalyzed conversion of L-arginine to L-citrulline (1, 36, 39 ). The first experiment tested the effects of estrogen and calcium on NO release. CaSki cells release NO constitutively in the extracellular medium (Fig. 7A and Ref. 17) . In estrogen-deficient cells, L-NAME, an NOS inhibitor (10), decreased NO release slightly; in estrogen-treated cells, L-NAME decreased NO release markedly to levels that were observed in estrogendeficient cells. This result indicates that most of the increase in NO release in estrogen-treated cells originates from NOS(s).
In estrogen-deficient cells, treatment with EGTAMn 2ϩ -ionomycin decreased NO release from 16 to 12 pmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 (Fig. 7A , P Ͻ 0.01, paired t-test). In estrogen-treated cells, NO release was fourfold greater than in estrogen-deficient cells (Fig. 7A) , and treatment with EGTA-Mn 2ϩ -ionomycin decreased NO release to levels that were observed in estrogendeprived cells (Fig. 7A) . This result indicates that most of the estrogen-induced increase in NO release is calcium dependent.
The second experiment tested the calcium requirements of NOS(s) in vitro, in broken cell preparations, . Addition of EGTA to chelate calcium to Ͻ0.1 mM decreased NOS activity to ϳ0.5 pmol ⅐ min Ϫ1 ⅐ mg DNA Ϫ1 , both in lysates of estrogentreated cells and in lysates of estrogen-deficient cells (Fig. 7B ). L-NAME had a similar effect to that of EGTA (Fig. 7B) . L-Arginine, a naturally occurring substrate for NOS, had no significant effect on NOS activity; however, coadministration of L-arginine with L-NAME blocked the inhibitory effect of L-NAME (Fig. 7B) . These results indicate that most of the estrogen-induced increase in NO release originates from calciumdependent, in vitro NOS(s)-dependent conversion of L-citrulline to L-arginine.
Three different broad categories of NOS isoforms have been characterized and classified according to the calcium dependency of the enzyme: the endothelial [eNOS (NOS-3)] and neuronal [bNOS (NOS-1)] isozymes exhibit strict dependency on intracellular calcium/calmodulin levels, whereas the inducible NOS [iNOS (NOS-2)] is less dependent on calcium (1, 36, 39) . Human cervical epithelial cells express mRNA for all three isoforms (17) , and estrogen has been shown to upregulate the eNOS (23) . In contrast, relatively little is known about the calcium dependence of the eNOS in human cervical cells. The third experiment tested the effects of calcium and estrogen on the expression of eNOS, bNOS, and iNOS mRNA using the RT-PCR technique. The present study confirmed our previous results that CaSki cells express mRNA for the eNOS, bNOS, and iNOS and that treatment with estrogen upregulated steady-state levels of eNOS mRNA (Fig. 7 and Ref. 17) . Treatment with 17␤-estradiol had no significant effect on the expression of mRNA for GAPDH, bNOS, or iNOS. In contrast, estrogen upregulated eNOS mRNA; densitometry analysis of three experiments revealed that estradiol increased the ratio of eNOS to GAPDH mRNA 9-, 17-, and 25-fold (Fig. 8) .
In estrogen-deficient cells, treatment with EGTAMn 2ϩ -ionomycin had no significant effect on the expression of mRNA of GAPDH, eNOS, bNOS, or iNOS (Fig. 8) ; densitometry analysis of three experiments revealed that the ratio of eNOS to GAPDH mRNA in cells treated with EGTA-Mn 2ϩ -ionomycin was 0.5, 1.0, and 1.3 compared with control cells. In estrogentreated cells, additional treatment with EGTA-Mn 2ϩ -ionomycin did not modulate the estrogen increase in eNOS mRNA (Fig. 8) . These results indicate that estrogen upregulates eNOS and that lowering cytosolic calcium does not modulate the effect of estrogen.
DISCUSSION
The results of the present study provide novel data about the regulation of transcervical permeability by estrogen and by cytosolic calcium. Treatment with estrogen augmented increases in permeability that were induced by ionomycin and hypertonicity. Although all three agents/conditions increase permeability by decreasing the resistance of the lateral intercellular space, R LIS (15, 20, 28) , the cellular mechanisms of action are different: estrogen increases permeability by fragmenting the cytoskeleton (present results and Ref. Fig. 7 . A: modulation of nitric oxide (NO) release from intact CaSki cells. Cells were grown on filters in steroid-free medium in the absence (ϪEstrogen) or presence (ϩEstrogen) of 10 nM 17␤-estradiol. NO release was measured in dishes containing cells incubated in 1.2 mM calcium before (control, filled bars) and after treatments with EGTA-Mn 2ϩ -ionomycin (as in Figs. 2 and 3 ; Low Ca) or after adding 1 mM N G -nitro-L-arginine methyl ester (L-NAME; see METH-ODS). *P Ͻ 0.01 compared with control/ϪEstrogen (paired t-test). **P Ͻ 0.01 compared with control/ϪEstrogen. ***P Ͻ 0.01 compared with control/ϩEstrogen (paired t-test). Bars are means Ϯ SD of 2 experiments with 3-6 filters in each experiment. B: modulation of nitric oxide synthase (NOS) activity in lysates of CaSki cells. Cells were grown on filters in steroid-free medium in the absence (ϪEs-trogen) or presence (ϩEstrogen) of estrogen. Cells were lysed, and reactions were carried out in the absence (control) or presence of one or more of the following agents: 1.2 mM EGTA, 1 mM L-NAME, or 1 mM L-arginine (L-Arg). *P Ͻ 0.01 compared with control in each group (paired t-test). Bars are means Ϯ SD of 3 experiments with 3-5 filters in each experiment. 16); ionomycin and hypertonicity generate a subluminal to luminal hydrostatic gradients. Ionomycin stimulates Cl Ϫ secretion, followed by water efflux (15, 20) ; hypertonicity stimulates water efflux directly (15) . In both cases, water moves from the cells into the intercellular space; water that accumulates in the basal compartment of the intercellular space dilates the space and generates a subluminal to luminal hydrostatic gradient (32, 45) . The effects of estrogen on G-actin and on the cytoskeleton can explain how estrogen augments the responses to ionomycin and hypertonicity; changes in cell size depend on the flexibility of the cytoskeleton, and cells with a fragmented cytoskeleton can adapt more readily to changes in cell volume (6, 7, 9, 44) .
Estrogen, ionomycin, and hypertonicity activate a common paracellular mechanism, namely, a decrease in R LIS (15, 20, 28) . This finding has physiological relevance because in vivo the main driving force for fluid transudation across the cervical epithelium is the pressure generated by the blood in the subepithelial space (14) , which is equivalent to a hydrostatic gradient in the subluminal to luminal direction.
The experiments of the present study also showed that baseline permeability and the responses to hypertonicity depend on cytosolic calcium. The results showed that 1) increases in cytosolic calcium had little effect on baseline permeability; in contrast, lowering cytosolic calcium decreased baseline permeability, suggesting that physiological resting steady-state cytosolic calcium levels induce a maximal degree of permeability. 2) Lowering cytosolic calcium attenuated the increase in permeability in response to hypertonicity, whereas increasing cytosolic calcium augmented the response. The critical factor relative to the status of cytosolic calcium was resting levels of cytosolic calcium, as determined by cellular calcium content, rather than the cell's ability to increase cytosolic calcium by mobilization from intracellular stores, since treatment with the endoplasmic reticulum calcium pump inhibitor thapsigargin had no significant effect on permeability (results not shown). 3) Lowering cytosolic calcium blocked the estrogen-induced increase in G-actin, and it attenuated the augmented increase in permeability in response to hypertonicity, indicating that the estrogen-related, hypertonicity-induced increase in permeability is calcium dependent.
The estrogen increase in G-actin and in the permeability involves four key signaling steps: the ␣-estrogen receptor, eNOS, NO, and cGMP (16, 17, 18, 24) . Agents that mimic effects of NO (e.g., SNP) and cGMP (e.g., 8-Br-cGMP) can increase G-actin and the permeability (present results and Refs. 17, 18, 28) . Lowering cytosolic calcium had no effect on the responses to SNP or to 8-Br-cGMP; in contrast, lowering cytosolic calcium abrogated the estrogen-induced increase in NO release from intact cells, and it attenuated the estrogen-induced increase in the conversion of L-citrulline to Larginine. In addition, estrogen increased expression of mRNA for the calcium-dependent eNOS. Collectively, these results suggest that the calcium-dependent ratelimiting step is NO synthesis by the calcium-dependent eNOS.
In estrogen-deficient cells bathed in low calcium, the responses to hypertonic gradients were mildly attenuated compared with responses in cells bathed in normal calcium, suggesting some involvement of calcium also in the response to hypertonicity. A possible explanation is that lowering calcium blocked the activity of calcium-dependent NOS(s) that produce(s) NO constitutively, even in cells grown in steroid-free conditions. This statement is supported by the findings that CaSki cells (present study) and other types of cultured human cervical epithelial cells express mRNA for all three NOS isoforms and that the cells constitutively secrete NO (present results and Ref. 17) . Another source of NO is from calcium-independent NOS; lowering cytosolic calcium abrogated the estrogen-induced increase in the conversion of L-citrulline to L-arginine, and the remaining NO activity could be blocked by L-NAME, indicating that some of the NO activity is contributed by calcium-independent mechanisms, possibly by the iNOS (33) . These results support our hypothesis (17) that cervical cells autoregulate permeability and maintain increased paracellular permeability by continuously secreting NO. Accordingly, the effect of NO in- volves autocrine/paracrine regulation of permeability: cells secrete NO, and NO can either act on the same cell (autocrine regulation) or diffuse into neighboring cells (paracrine regulation). This hypothesis explains the slow decrease in permeability in cultures treated with EGTA-Mn 2ϩ -ionomycin; depletion of calcium may have decreased NO synthesis and abrogated its effect on permeability (4) . It also explains the greater decrease in permeability in estrogen-treated cells than in estrogen-deficient cells because estrogen increases NO (present results and Refs. 8, 12, 42) , and blocking NO synthesis would have a greater impact on permeability.
Previous studies in smooth muscle cells reported that estrogen could directly block calcium channels and attenuate calcium influx, thus lowering cytosolic calcium (5, 35, 37, 48) . The present experiments show similar trends in human cervical epithelial cells in that baseline levels of cytosolic calcium were lower in estrogen-treated cervical cells than in estrogen-deficient cells. The mechanism by which estrogen lowers cytosolic calcium in cervical epithelial cells is unclear. Changing extracellular calcium in the range of 0.6-4.0 mM increased cytosolic calcium in a concentrationrelated manner, both in estrogen-treated cells and in estrogen-deficient cells. Extracellular calcium levels Ͼ1.2 mM increased cytosolic calcium more in estrogendeficient cells than in estrogen-treated cells, raising the possibility that estrogen blocks calcium channels also in cervical cells.
Relatively little is known about the biological role of the lowered cytosolic calcium in estrogen-treated cells. Because both estrogen and calcium upregulate NO (present results), it is possible that the lowered cytosolic calcium controls NO activity and prevents apoptosis (3, 29) . However, more studies are needed to clarify this issue.
The results of the present study may be important for understanding regulation of cervical secretions in vivo because agonists that elevate cytosolic calcium can activate the eNOS (36, 39) . Secretagogues, neurotransmitters, and agonists that participate in the inflammatory response can stimulate an increase in cytosolic calcium in human cervical cells (23) . These agents may stimulate NO production, increase G-actin, and lead to increased paracellular permeability. Increased permeability will allow greater fluxes of fluids and solutes from the blood into the cervical canal and augment secretion of cervical mucus. In cervical cells, estrogen increases NO by upregulation of the calcium-dependent eNOS (present study). Subsequently, changes in cytosolic calcium are likely to affect permeability more in estrogen-treated cells than in estrogen-deprived cells. This conclusion may have pharmacological significance in the sense of modulating cervical secretions directly by NO-related agents, but more studies are needed to clarify the effects in women.
